This week, we need to do work to address a component of our application that requires immediate attention. As a result, you may experience ERA to be intermittently available. We apologize for any inconvenience this may cause, and thank you for your patience as we attend to the care and feeding of ERA!
Communities and Collections
Usage
- 26 views
- 88 downloads
Melatonin for cognitive impairment (Protocol)
-
- Author(s) / Creator(s)
-
This is the protocol for a review and there is no abstract. The objectives are as follows: The primary objective is a systematic review of evidence relating to clinical efficacy and safety of melatonin in treatment of manifestations of dementia or cognitive impairment (CI).
-
- Date created
- 2002
-
- Subjects / Keywords
-
- Type of Item
- Article (Published)
-
- License
- © 2002 The Cochrane Collaboration for John Wiley & Sons, Ltd. This version of this article is open access and can be downloaded and shared. The original author(s) and source must be cited.